STAT - Reporting from the frontiers of health and medicine

Biotech

Health

Health Tech

Business Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
Biotech In a pivot, Decibel Therapeutics loses its founding CEO — and some of its discovery programs
Business Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter
First Opinion Biotech can — and must — reshape the pricing debate and protect future innovation
Politics With new rules, FDA aims to spark competition, lower prices for expensive gene therapies

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Biotech earnings preview: Unsettled investors hoping for strong 2020 outlooks
Drug makers face more securities-fraud lawsuits, and so do cannabis companies
Pharmalittle: Novartis says coronavirus not disrupting supply chain, for now; FDA releases new gene therapy policies

Politics

Health

Health

Health

Health

Health

Health The coronavirus questions that scientists are racing to answer
Biotech Three star scientists announce plan to solve biotech’s ‘missing women’ problem
Health Tech In coronavirus response, AI is becoming a useful tool in a global outbreak, data experts say
In the Lab DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations
Health Containing new coronavirus may not be feasible, experts say, as they warn of possible sustained global spread